Who owns Biolinerx Ltd sponsored ads?
- Ticker: BLRX
- CUSIP Number: 09071m205
Tip: Access positions for across all investors
Analyze quarterly positions in Biolinerx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biolinerx stock
Who bought or sold Biolinerx Ltd sponsored ads this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 377k | $422k | 11% | Mar 2024 |
|
| Morgan Stanley | 291k | $326k | 66% | Mar 2024 |
|
| Values First Advisors | 204k | $228k | 290% | Mar 2024 |
|
| LPL Financial | 100k | $112k | -12% | Mar 2024 |
|
| Atria Wealth Solutions | 99k | $111k | -10% | Mar 2024 |
|
| Pvg Asset Management | 62k | $97k | 100% | Dec 2023 |
|
| Envestnet Asset Management | 54k | $61k | -6% | Mar 2024 |
|
| Geode Capital Management | 40k | $45k | 25% | Mar 2024 |
|
| Rathbones Brothers | 40k | $45k | 0% | Mar 2024 |
|
| Geneos Wealth Management | 39k | $43k | -5% | Mar 2024 |
|
| Citadel Advisors | 36k | $41k | -44% | Mar 2024 |
|
| Wells Fargo & Company | 32k | $36k | 275% | Mar 2024 |
|
| XTX Topco | 32k | $35k | 35% | Mar 2024 |
|
| National Asset Management | 21k | $39k | 10% | Mar 2024 |
|
| Rhumbline Advisers | 18k | $21k | -2% | Mar 2024 |
|
| Cetera Investment Advisers | 18k | $20k | 21% | Mar 2024 |
|
| Two Sigma Securities | 17k | $19k | 100% | Mar 2024 |
|
| Cutter & CO Brokerage | 17k | $19k | 0% | Mar 2024 |
|
| Qube Research & Technologies | 14k | $16k | 39429% | Mar 2024 |
|
| Creative Planning | 13k | $15k | -11% | Mar 2024 |
|
| UBS Group | 13k | $14k | 4090% | Mar 2024 |
|
| Nemes Rush Group | 12k | $13k | 0% | Mar 2024 |
|
| Gradient Investments | 9.0k | $10k | 374% | Mar 2024 |
|
| Goss Wealth Management | 4.3k | $4.8k | 0% | Mar 2024 |
|
| GAMMA Investing | 4.0k | $4.5k | 100% | Mar 2024 |
|
| Group One Trading | 3.2k | $3.6k | 100% | Mar 2024 |
|
| Simplex Trading | 2.0k | $2.0k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 1.2k | $1.2k | -92% | Mar 2024 |
|
| Tradewinds Capital Management | 200.00 | $224.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 66.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Biolinerx?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Dec 2023 | 30k | $48k |
| Jpmorgan Chase & Co | Dec 2023 | 23k | $36k |
| NorthRock Partners | Dec 2023 | 17k | $27k |
| Allen Mooney & Barnes Investment Advisors | Dec 2023 | 15k | $24k |
| Ronald Blue Trust | Dec 2023 | 117.00 | $0 |